Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials.
Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Dreyfus I, Kakavand H, Ariannejad H, Gupta A, Madhavan MV, Van Tassell BW, Jimenez D, Monreal M, Vaduganathan M, Fanikos J, Dixon DL, Piazza G, Parikh SA, Bhatt DL, Lip GY, Stone GW, Krumholz HM, Libby P, Goldhaber SZ, Bikdeli B.
Talasaz AH, et al. Among authors: piazza g.
medRxiv [Preprint]. 2021 May 4:2021.05.03.21256468. doi: 10.1101/2021.05.03.21256468.
medRxiv. 2021.
PMID: 33972948
Free PMC article.
Updated.
Preprint.